RV Sense Polarity Overview RV Sense Polarity is a feature available to program the RV sensing vector between true bipolar and integrated bipolar. It offers a noninvasive option to troubleshoot T wave oversensing and/or a reduction in R wave amplitudes. It is only available in ICDs and requires that a true bipolar lead be implanted. Programming The RV sensing vector is programmable via the RV Sense Polarity parameter. RV Sense Polarity can be programmed to either Bipolar (tip-to-ring) or Tip to Coil (integrated bipolar). To program this feature go to Params -> Pacing… Feature Operation The RV Sense Polarity feature determines which electrodes the RV lead uses to sense. It can be programmed to either true bipolar, sensing between the tip and ring electrodes, or integrated bipolar, sensing between the tip and RV coil electrodes. Changing the RV Sense Polarity between these two configurations may change the amplitude of the RV sensed EGM. This change may result in an increase or decrease in the R wave and T wave amplitude depending on lead position. This feature can offer a noninvasive option for troubleshooting T wave oversensing. © 2013 Medtronic, Inc. www.medtronicfeatures.com Page 1 of 3 C Caution should be taken in n changing th he RV Sense e Polarity beccause the ab bility of the de evice to detecct and se ense fine VF is changed. Reevaluatio on of the ability of the devvice to sense VF should b be considered d through de efibrillation te esting. C Considerations: eature does not n work for dedicated d inttegrated bipo olar defibrillattion leads, siince there is no RV This fe ring electrode. Note that changing g the RV sense vector willl not affect th he RV pace p polarity, whicch is nonprogra ammable. The ve entricular sen nsing electro odes included d in Sensing Test measurrements depe end on the progra ammed RV Sense S Polarity value. D Devices IC CDs EveraTM XT VR, Evera XT DR, Evera S VR, Evera S DR, Proteccta® XT VR, Protecta XT DR, Protecta a VR, ® S VR, Secura DR, Virtuoso® II VR, Virtuoso o II DR, Maximo® II VR, M Maximo II DR R Protecta DR, Secura C CRT-D V VivaTM XT CR RT-D, Viva S CRT-D, Prottecta XT CRT T-D, Protecta a CRT-D, Co onsulta® CRT T-D, Concerto o® II CRTD D, Maximo II CRT-D C So ources: Medtro onic Protecta® XT X DR Clinicia an Manual; Med dtronic Protecta a® XT CRT-D C Clinician Manu ual. his document is s provided for general g educattional purposes s only and shou uld not be conssidered the excclusive source for this Th tyype of information. At all times s, it is the profe essional respon nsibility of the p practitioner to e exercise indepe endent clinical jjudgment in a particular situa ation. Changes in a patient’s disease d and/orr medications m may alter the effficacy of a devvice’s programm med arameters or re elated features and results ma ay vary. The de evice functiona ality and progra amming describ bed in this docu ument are pa ba ased on Medtro onic products and a can be refe erenced in the published devi ce manuals. © 2013 Medtron nic, Inc. ww w.medtronic cfeatures.co om Page 2 of 3 Indications, Safety, and Warnings Brief Statement: ICDs and CRT ICDs Indications Implantable cardioverter defibrillators (ICDs) are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. Cardiac resynchronization therapy (CRT) ICDs are indicated for ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias and for providing cardiac resynchronization therapy in heart failure patients who remain symptomatic despite optimal medical therapy, and meet any of the following classifications: New York Heart Association (NYHA) Functional Class III or IV and who have a left ventricular ejection fraction ≤ 35% and a prolonged QRS duration. Left bundle branch block (LBBB) with a QRS duration ≥ 130 ms, left ventricular ejection fraction ≤ 30%, and NYHA Functional Class II. Contraindications ICDs and CRT ICDs are contraindicated in patients whose ventricular tachyarrhythmias may have transient or reversible causes, patients with incessant VT or VF, and for patients who have a unipolar pacemaker. In CRT ICD systems, the leads are contraindicated for patients with coronary venous vasculature that is inadequate for lead placement, as indicated by venogram. The lead is also contraindicated in patients for whom a single dose of 1.0 mg of dexamethasone acetate and/or dexamethasone sodium phosphate may be contraindicated. Warnings/Precautions Changes in a patient’s disease and/or medications may alter the efficacy of the device’s programmed parameters. Patients should avoid sources of magnetic and electromagnetic radiation to avoid possible underdetection, inappropriate sensing and/or therapy delivery, tissue damage, induction of an arrhythmia, device electrical reset or device damage. Do not place transthoracic defibrillation paddles directly over the device. Additionally, for CRT ICDs, certain programming and device operations may not provide cardiac resynchronization. Potential Complications Potential complications include, but are not limited to, rejection phenomena, erosion through the skin, muscle or nerve stimulation, oversensing, failure to detect and/or terminate arrhythmia episodes, and surgical complications such as hematoma, infection, inflammation, and thrombosis. An additional complication for ICDs and CRT ICDs is the acceleration of ventricular tachycardia. See the device manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 1-800-328-2518 and/or consult Medtronic’s website at www.medtronic.com. Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician. World Headquarters Medtronic, Inc. 710 Medtronic Parkway Minneapolis, MN 55432-5604 USA © 2013 Medtronic, Inc. Tel: (763) 514-4000 Fax: (763) 514-4879 Toll-free: 1 (800) 328-2518 (24-hour technical support for physicians and medical professionals) www.medtronicfeatures.com Page 3 of 3
© Copyright 2024 ExpyDoc